New York, United States, November 13th, 2024, Chainwire

Pulse, a Web3 health tech startup reshaping how people manage and potentially benefit from their health data, today announced the close of its $1.8 million pre-seed round. Co-led by Collab+Currency and Lemniscap, with participation from Delphi Digital and Lattice Fund, the round also attracted notable angel investors, including Solana co-founder Anatoly Yakovenko and Santiago R Santos.

This funding will drive Pulse’s mission to create digital twins—secure, virtual profiles that bring us closer to personalized, preventative healthcare. Pulse’s platform tackles the healthcare trilemma of balancing privacy, personalization, and prevention, all while giving users complete control over their data.

Pulse’s recent traction underscores growing demand: the first two pre-order batches of its wearable sold out within 48 hours, which can highlight consumer interest in a platform that prioritizes data ownership and personalized health insights. This investment will accelerate Pulse’s platform and wearable development, giving an opportunity to enable more people to benefit from personalized health insights while supporting breakthroughs in healthcare.

Pulse’s digital twin technology aggregates data from wearables, electronic health records, and diagnostics into a comprehensive, unified health profile. Pulse empowers users to securely share this data with trusted partners—such as researchers or healthcare providers—in return for rewards. This approach protects privacy while unlocking actionable health insights that improve wellness and drive medical research forward.

“Pulse is all about putting individuals in control of their data and allowing them to turn their vitals into value,” said River Tamoor Baig, CEO of Pulse. “With this funding, we’re transforming untapped health data into insights that empower users and move the entire healthcare ecosystem forward.”

The Pulse wearable, integrated with the platform, tracks essential health metrics like heart rate variability, sleep patterns, and blood oxygen levels across 50+ activities. This real-time data fuels AI-powered, personalized insights that help users make informed choices for better health. By choosing to share this information with third parties under strict consent protocols, users can actively contribute to clinical research and earn rewards for their contributions.

In the healthcare sector, AI is transforming everything from drug discovery to personalized care. Despite this growth, a staggering 97% of health data generated by hospitals remains unused due to privacy concerns, regulatory restrictions, and fragmented systems that hinder seamless data sharing.

Hospitals, health systems, and other data sources are often reluctant to share data because of the security risks, regulatory requirements like HIPAA, and the costs associated with managing data flows. Pulse is designed to overcome these barriers by prioritizing data privacy and interoperability, making it easier to securely share data in a way that can benefit both individuals and the healthcare system.

About Pulse

Pulse is changing the future of healthcare with digital twin technology that balances privacy, personalization, and prevention. By putting individuals in control of their health data, Pulse brings real value to users and drives medical innovation through its open health network.

For more information, users can visit pulse.site or follow Pulse on Twitter.

Contact

Founder
Lorcan Byrne
ForewordVenture
lorcan@forewordventure.com

Disclaimer: Press release sponsored by our commercial partners.

Daily Debrief Newsletter

Start every day with the top news stories right now, plus original features, a podcast, videos and more.